Clinical Trials
2 trialsNCT06231680 2024-03-29
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Phase 2 Unknown
NCT05569668 2022-10-06
Neoadjuvant Chemotherapy Compared With Surgery for Esophageal Carcinoma
Henan Cancer Hospital
Completed